Cite
SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients With Central Retinal Vein Occlusion.
MLA
Scott, Ingrid U., et al. “SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients With Central Retinal Vein Occlusion.” American Journal of Ophthalmology, vol. 170, Oct. 2016, pp. 25–31. EBSCOhost, https://doi.org/10.1016/j.ajo.2016.07.011.
APA
Scott, I. U., VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., & Figueroa, M. (2016). SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients With Central Retinal Vein Occlusion. American Journal of Ophthalmology, 170, 25–31. https://doi.org/10.1016/j.ajo.2016.07.011
Chicago
Scott, Ingrid U, Paul C VanVeldhuisen, Michael S Ip, Barbara A Blodi, Neal L Oden, and Maria Figueroa. 2016. “SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients With Central Retinal Vein Occlusion.” American Journal of Ophthalmology 170 (October): 25–31. doi:10.1016/j.ajo.2016.07.011.